Lindsey Marie Hartley - 16 Mar 2026 Form 4 Insider Report for Axogen, Inc. (AXGN)

Role
CFO
Signature
/s/ Marc Began, as attorney-in-fact for Lindsey Hartley
Issuer symbol
AXGN
Transactions as of
16 Mar 2026
Net transactions value
$0
Form type
4
Filing time
18 Mar 2026, 16:10:01 UTC
Previous filing
27 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hartley Lindsey Marie CFO 13631 PROGRESS BLVD., SUITE 400, ALACHUA /s/ Marc Began, as attorney-in-fact for Lindsey Hartley 18 Mar 2026 0002068693

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXGN Common Stock Options Exercise +4,000 +7.2% $0.000000* 59,276 16 Mar 2026 Direct F1
transaction AXGN Common Stock Tax liability -1,574 -2.7% $32.84* 57,702 16 Mar 2026 Direct F2
transaction AXGN Common Stock Options Exercise +5,000 +8.7% $0.000000* 62,702 16 Mar 2026 Direct F1
transaction AXGN Common Stock Tax liability -1,968 -3.1% $32.84* 60,734 16 Mar 2026 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXGN Restricted Stock Units Options Exercise +4,000 $0.000000* 4,000 16 Mar 2026 Common Stock 4,000 $0.000000 Direct F3, F4
transaction AXGN Restricted Stock Units Options Exercise +5,000 $0.000000* 5,000 16 Mar 2026 Common Stock 5,000 $0.000000 Direct F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This reflects the number of restricted stock units ("RSUs") that vested on March 16, 2026.
F2 This represents the number of shares of Common Stock that have been withheld by the issuer to satisfy tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent an open market sale.
F3 Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
F4 All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2027 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vested on March 16, 2025 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares are delivered to the reporting person upon the vesting date.
F5 All shares of Axogen Inc. common stock underlying the restricted stock units are fully vested on March 16, 2026 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vested on March 16, 2024 (24 months from the grant date) and an additional 25% of the aggregate shares vested each 12 months thereafter. Vested shares are delivered to the reporting person upon the vesting date.